Lea Sani
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Lea Sani has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Jean-François Landrier
Aix Marseille Univ, INSERM, INRAE, C2VN, Marseille, France
3 shared publications - Lourdes Mounien
Aix Marseille Univ, INSERM, INRAE, C2VN, Marseille, France
2 shared publications Catherine Tardivel
Aix‐Marseille Université C2VN INRAE INSERM Marseille 13000 France
1 shared publicationEva Seipelt
Aix‐Marseille Université C2VN INRAE INSERM Marseille 13000 France
1 shared publicationImene Bennour
Aix‐Marseille Université C2VN INRAE INSERM Marseille 13000 France
1 shared publication- Jean-Charles Martin
Aix Marseille Univ., C2VN, INRAE, INSERM, Marseille, France
1 shared publication
Latest Publications
- Open Access
- 22 May 2026
- Published by Royal Society of Chemistry (RSC) in Food & Function
- Vol. 17 (12) , 5213-5232
Impact of tomatoes and tomato-derived products on obesity and cardiometabolic health: a systematic review and meta-analysis
This article provides modest but biologically consistent evidence on the role of tomato and tomato-based product intake on several parameters linked to adiposity and obesity.
- 22 May 2026
- Published by Royal Society of Chemistry (RSC) in Food & Function
- Vol. 17 (12) , 5213-5232
Open AccessImpact of tomatoes and tomato-derived products on obesity and cardiometabolic health: a systematic review and meta-analysis
This article provides modest but biologically consistent evidence on the role of tomato and tomato-based product intake on several parameters linked to adiposity and obesity.
- Open Access
- 27 November 2023
- Published by Wiley in Molecular Nutrition & Food Research
- Vol. 68 (1) , e2300290
Maternal Vitamin D Deficiency in Mice Sex‐Dependently Affects Hepatic Lipid Accumulation in Offspring
Scope: Vitamin D deficiency (VDD) is becoming a global issue and low 25‐hydroxyvitamin D (25(OH)D) plasma levels have been linked to hepatic steatosis in adulthood. Nevertheless, the impact of maternal VDD on lipid metabolism and hepatic steatosis remains poorly documented, especially under obesogenic condition. The goal of this study is to assess the effects of maternal VDD on hepatic lipid accumulation in adult offspring fed a normal or obesogenic diet.Methods and results: Several approaches are implemented including histology and lipidomics on the liver in both males and females. No major impact of high‐fat (HF) or VDD is observed at histological level in both males and females. Nevertheless, in males born from VDD mice and fed an HF diet, an increase of total lipids and modulation of the relative lipid species distribution characterized by a decrease of triglycerides and increase of phospholipids is observed. In female no major lipid profile is noticed.Conclusion: Maternal VDD combined with a HF diet in male may predispose to hepatic hypertrophia, with a specific lipid profile. Such observations reinforce our knowledge of the impact of maternal VDD on hepatic programming in the offspring.
- 27 November 2023
- Published by Wiley in Molecular Nutrition & Food Research
- Vol. 68 (1) , e2300290
Open AccessMaternal Vitamin D Deficiency in Mice Sex‐Dependently Affects Hepatic Lipid Accumulation in Offspring
Scope: Vitamin D deficiency (VDD) is becoming a global issue and low 25‐hydroxyvitamin D (25(OH)D) plasma levels have been linked to hepatic steatosis in adulthood. Nevertheless, the impact of maternal VDD on lipid metabolism and hepatic steatosis remains poorly documented, especially under obesogenic condition. The goal of this study is to assess the effects of maternal VDD on hepatic lipid accumulation in adult offspring fed a normal or obesogenic diet.Methods and results: Several approaches are implemented including histology and lipidomics on the liver in both males and females. No major impact of high‐fat (HF) or VDD is observed at histological level in both males and females. Nevertheless, in males born from VDD mice and fed an HF diet, an increase of total lipids and modulation of the relative lipid species distribution characterized by a decrease of triglycerides and increase of phospholipids is observed. In female no major lipid profile is noticed.Conclusion: Maternal VDD combined with a HF diet in male may predispose to hepatic hypertrophia, with a specific lipid profile. Such observations reinforce our knowledge of the impact of maternal VDD on hepatic programming in the offspring.
- Open Access
- 25 July 2023
- Published by MDPI AG in Antioxidants
- Vol. 12 (8) , 1481
Poplar Propolis Improves Insulin Homeostasis in Non-Diabetic Insulin-Resistant Volunteers with Obesity: A Crossover Randomized Controlled Trial
Propolis, a natural resinous mixture rich in polyphenols, produced by bees from a variety of plant sources, has shown significant therapeutic effects and may prevent the development of certain chronic diseases like type 2 diabetes mellitus (T2DM). The objective of this study was to evaluate the effect of supplementation with standardized poplar propolis extract powder (PPEP) on insulin homeostasis in non-diabetic insulin-resistant volunteers with obesity. In this randomized, controlled, crossover trial, nine non-diabetic insulin-resistant volunteers with obesity, aged 49 ± 7 years, were subjected to two periods of supplementation (placebo and PPEP) for 3 months. Blood samples and anthropomorphic data were collected at baseline and at the end of each phase of the intervention. PPEP supplementation improved insulin sensitivity by significantly decreasing the percentage of insulin-resistant subjects and the insulin sensitivity Matsuda index (ISI-M). According to this study, supplementation with standardized PPEP for 3 months in non-diabetic insulin-resistant volunteers with obesity led to an improvement in insulin homeostasis by its effect on insulin resistance and secretion. This study suggests that poplar propolis has a preventive effect on the physiopathological mechanisms of T2DM and, therefore, that it can help to prevent the development of the disease.
- 25 July 2023
- Published by MDPI AG in Antioxidants
- Vol. 12 (8) , 1481
Open AccessPoplar Propolis Improves Insulin Homeostasis in Non-Diabetic Insulin-Resistant Volunteers with Obesity: A Crossover Randomized Controlled Trial
Propolis, a natural resinous mixture rich in polyphenols, produced by bees from a variety of plant sources, has shown significant therapeutic effects and may prevent the development of certain chronic diseases like type 2 diabetes mellitus (T2DM). The objective of this study was to evaluate the effect of supplementation with standardized poplar propolis extract powder (PPEP) on insulin homeostasis in non-diabetic insulin-resistant volunteers with obesity. In this randomized, controlled, crossover trial, nine non-diabetic insulin-resistant volunteers with obesity, aged 49 ± 7 years, were subjected to two periods of supplementation (placebo and PPEP) for 3 months. Blood samples and anthropomorphic data were collected at baseline and at the end of each phase of the intervention. PPEP supplementation improved insulin sensitivity by significantly decreasing the percentage of insulin-resistant subjects and the insulin sensitivity Matsuda index (ISI-M). According to this study, supplementation with standardized PPEP for 3 months in non-diabetic insulin-resistant volunteers with obesity led to an improvement in insulin homeostasis by its effect on insulin resistance and secretion. This study suggests that poplar propolis has a preventive effect on the physiopathological mechanisms of T2DM and, therefore, that it can help to prevent the development of the disease.